Respiratory therapeutic devices market to reach $35.19 billion by 2030

The Business Research Company says the global respiratory devices and equipment (therapeutic) market will rise from $23.68 billion in 2025 to $35.19 billion by 2030, driven by chronic respiratory disease, homecare adoption and connected-device demand. Asia-Pacific was the largest regional market in 2025, while a free sample and full report are available online.

Why it matters: - The respiratory devices and equipment (therapeutic) market is tied to care for COPD, asthma, chronic bronchitis and sleep-related breathing disorders. - Demand for these devices reflects broader pressure on health systems from chronic respiratory disease, aging populations and home-based care. - The market’s growth points to rising use of therapeutic devices that help patients breathe better, manage symptoms and improve quality of life.

What happened: - The Business Research Company published its 2026 market report on respiratory devices and equipment (therapeutic) on August 28, 2026. - The report estimates the market will grow from $23.68 billion in 2025 to $25.59 billion in 2026, an 8.0% CAGR. - The report forecasts the market will reach $35.19 billion by 2030, with an 8.3% CAGR. - A free sample is available here. - The full report is available here.

The details: - The report links past growth to rising chronic respiratory disease, higher hospital admissions for respiratory issues, greater use of homecare medical devices, ventilator technology advances and population aging. - The forecast is supported by demand for remote patient monitoring, home-based respiratory therapies, smart medical devices and telehealth-supported respiratory treatment. - The report also points to stronger emphasis on early management of respiratory disease. - Expected trends include connected respiratory devices, portable and homecare equipment, smart monitoring integrations, non-invasive ventilation and more patient-centered device design. - Smoking remains a major demand driver because smokers can develop COPD, chronic bronchitis and lung cancer that require long-term respiratory management. - Statistics Canada reported that cigarette sales in Canada totaled 1.1 billion units in March 2024, down 24.0% from March 2023.

Between the lines: - The market outlook suggests respiratory care is moving away from purely hospital-based treatment and toward connected, at-home and monitored care models. - The report’s emphasis on smart devices and telehealth signals that device makers are competing on data, convenience and integration, not just core respiratory function. - Asia-Pacific’s lead position suggests healthcare infrastructure growth and patient demand are combining to make the region the center of market expansion.

What's next: - The report expects wider adoption of home-based therapies and connected devices to keep pushing the market higher through 2030. - The company says its 2026 report now includes market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - The Business Research Company lists contact details for expert questions and promotes its company site and social channels for follow-up.